HAL (France)
open access
Antibody functionalized thiolated chitosan stabilized silver nanoparticles as theranostics toward visceral leishmaniasis
Leishmaniasis (VL) is a neglected disease caused by Leishmania protozoa, transmitted through insect vectors, and can be fatal without adequate treatment. Current therapies are hindered by issues such as drug resistance and side effects, making rapid diagnosis essential. Biosensors are being explored
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.#672466
- First imported case of New World leishmaniasis in Romania: diagnostic and therapeutic challenges in a non-endemic country#149519
- Intralesional Antimony for Bolivian Cutaneous Leishmaniasis#855500
- Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)#217100
- Microscopy and Polymerase Chain Reaction on Giemsa-Stained Smears: A Combined Approach for Cutaneous Leishmaniasis Diagnosis#280361
Record · ID 818545
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive